Drug Type Biological products  | 
Synonyms  | 
Target  | 
Action stimulants  | 
Mechanism SGSH stimulants(N-sulphoglucosamine sulphohydrolase stimulants)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Mucopolysaccharidosis III | Preclinical | United States   | 22 Mar 2022 | 





